Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 51 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Emergency Contraception Clear all

Conditions: Preconception Care
Interventions: "video doctor," computer module; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 446 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Contraception
Interventions: Emergency contraception website, Emergency contraception video; Other
Lead sponsor: Planned Parenthood League of Massachusetts; Other
Eligibility: 18 Years to 29 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Contraception
Interventions: Copper IUD, Levonorgestrel IUD; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 711 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 6
States / cities: Logan, Utah • Ogden, Utah • Orem, Utah + 3 more

Conditions: Contraception Behavior
Interventions: Education Arm; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 15 Years to 21 Years · Male only
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: IUD, Contraceptive Implant, Contraception, Birth Control, Emergency Contraception
Interventions: Copper T-380 IUD, LNG IUD, Contraceptive implant Nexplanon, Depo-Provera; Drug · Device
Lead sponsor: University of Utah; Other
Eligibility: 15 Years to 45 Years · Female only
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: West Valley City, Utah

Conditions: Contraception
Interventions: ENG implant, oral ulipristal acetate; Device · Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Emergency Contraception
Interventions: Use Phase (Ulipristal Acetate, 30 mg); Drug
Lead sponsor: HRA Pharma; Industry
Eligibility: Female only
Enrollment: 1,270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 34
States / cities: Rancho Cucamonga, California • Boulder, Colorado • Denver, Colorado + 27 more

Conditions: Pregnancy in Adolescence, Counseling, Contraception Behavior
Interventions: Contraception Counseling; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 15 Years to 18 Years · Female only
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Kansas City, Missouri • Philadelphia, Pennsylvania

Conditions: Pregnancy Prevention
Interventions: Levonorgestrel 1.5 milligram, Meloxicam 15 milligram, calcium carbonate 750 milligram; Drug · Other
Lead sponsor: InnovaGyn, Inc.; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Raleigh, North Carolina

Conditions: Contraception
Interventions: Ulipristal Acetate, Levonorgestrel; Drug
Lead sponsor: Kimberly Myer; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 532 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 18
States / cities: Los Angeles, California • Sacramento, California • San Francisco, California + 14 more

Conditions: Contraception
Interventions: Drospirenone-only pill; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Emergency Contraception, Contraception
Interventions: Depot-Medroxyprogestereone Acetate; Drug
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 39 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Contraception
Interventions: Ulipristal Acetate, Levonorgestrel (LNG)/Ethinyl estradiol birth control pill; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Obesity
Interventions: Levonorgestrel 1.5mg by mouth once; Drug
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: HIV Infections, Tuberculosis
Interventions: Levonorgestrel (LNG); Drug
Lead sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections; Network
Eligibility: 16 Years and older · Female only
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 7
States / cities: Chicago, Illinois • New York, New York • Chapel Hill, North Carolina + 3 more

Conditions: Obesity, Contraception
Interventions: UPA-ECx1, UPA-ECx2; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Pregnancy Prevention
Interventions: Levonorgestrel 1.5mg, Meloxicam 15 mg, Placebo; Drug · Other
Lead sponsor: InnovaGyn, Inc.; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Raleigh, North Carolina

Conditions: Emergency Contraception
Interventions: ella; Drug
Lead sponsor: HRA Pharma; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Reproductive Behavior, Sexual Behavior, Adolescent Behavior, Contraception
Interventions: Dr. Erica; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 14 Years to 19 Years · Female only
Enrollment: 146 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Pregnancy
Interventions: levonorgestrel 0.75mg taken twice 12 hours apart (Plan B) and condoms; Drug
Lead sponsor: University of Washington; Other
Eligibility: 16 Years to 60 Years · Female only
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: HIV Infections, Contraception, Pharmacokinetics
Interventions: levonorgestrel, efavirenz; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Denver, Colorado • Providence, Rhode Island

Conditions: Contraception
Interventions: Etonogestrel implant; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Emergency Contraception
Interventions: CDB-2914, levonorgestrel; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,672 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2001
U.S. locations: 6
States / cities: Los Angeles, California • Denver, Colorado • New York, New York + 3 more

Conditions: Contraception
Interventions: Contraceptive Training and Education, Placebo Nutrition Education; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 25 Years · Female only
Enrollment: 2,086 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Computer-assisted Preventive Health Education for Women of Reproductive Age in Urgent Care Settings

Targeted Video Messaging About Emergency Contraception

RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC

Hormonal Contraceptive Health Education for Adolescent Males

Quick Start of Highly Effective Contraception

Ovarian Function With ENG Implant and UPA Use

A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions

Reducing Adolescent Pregnancy

Phase II Study of Ovulation in Obese Women

Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg

Drospirenone-only Pill as Emergency Contraception

Depot Medroxyprogesterone Acetate as Emergency Contraception

Impact of Combined Hormonal Contraceptives on UPA

Effects of Obesity on Pharmacokinetics of the Levonorgestrel Emergency Contraceptive Pill

Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA

Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days

Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

Reducing Teen Pregnancy in the Emergency Department

Randomized Trial of Advanced Provision Emergency Contraception Among Women With Gonorrhea or Chlamydia

A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication

Etonogestrel Implant as Emergency Contraception

Efficacy Trial of CDB 2914 for Emergency Contraception

UCSF College Health Study on Contraceptive Training and Education at Community Colleges